Search Within

Ying Zhang Mazzu

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (15)
Groups
  1. Sloan Kettering Institute Postdocs (34)
  2. Department of Medicine (29)
  3. Genitourinary Oncology Service (29)
  4. Solid Tumor Oncology Division (29)
  5. GSK Faculty (9)
  6. Human Oncology and Pathogenesis Program (5)

More Groups

People
  1. Philip Kantoff (29)
  2. Goutam Chakraborty (27)
  3. Yuki Yoshikawa (23)
  4. Subhiksha Nandakumar (21)
  5. Lina Jehane (14)
  6. Mohammad Atiq (14)

More People

Years
  1. 2022 (4)
  2. 2021 (4)
  3. 2020 (7)
  4. 2019 (10)
  5. 2018 (6)
  6. 2017 (1)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Cancer Research (9)
  3. Clinical Cancer Research (4)
  4. Molecular Oncology (4)
  5. American Journal of Chinese Medicine (1)
  6. Annals of Surgical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (14)
  2. American Society of Clinical Oncology (10)
  3. FEBS Press (4)
  4. Nature Publishing Group (2)
  5. American Society for Clinical Investigation (1)
  6. Elsevier Inc. (1)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A comparative analysis of fraction genome altered vs tumor mutational count in prostate cancer
    Meeting Abstract

    Chakraborty, G.; Atiq, M.; Nandakumar, S.; Mazzu, Y. Z.; Armenia, J.; Yoshikawa, Y.; Khan, N.; Lee, G. S. M.; Mucci, L.; Kantoff, P. W.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer
    Journal Article

    Mazzu, Y. Z.; Yoshikawa, Y.; Nandakumar, S.; Chakraborty, G.; Armenia, J.; Jehane, L. E.; Lee, G. S. M.; Kantoff, P. W.
    Molecular Oncology (2019)

    Fulltext@MSK | Save
  • A novel mechanism driving poor-prognosis prostate cancer: Overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2)
    Journal Article

    Mazzu, Y. Z.; Armenia, J.; Chakraborty, G.; Yoshikawa, Y.; Coggins, S. A.; Nandakumar, S.; Gerke, T. A.; Pomerantz, M. M.; Qiu, X.; Zhao, H.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Low expression of the androgen-induced tumor suppressor gene PLZF and lethal prostate cancer
    Journal Article

    Stopsack, K. H.; Gerke, T.; Tyekucheva, S.; Mazzu, Y. Z.; Lee, G. S. M.; Chakraborty, G.; Abida, W.; Mucci, L. A.; Kantoff, P. W.
    Cancer Epidemiology Biomarkers and Prevention (2019)

    Fulltext@MSK | Save
  • miR-193b regulates tumorigenesis in liposarcoma cells via PDGFR, TGFβ, and Wnt signaling
    Journal Article

    Mazzu, Y. Z.; Hu, Y.; Shen, Y.; Tuschl, T.; Singer, S.
    Scientific Reports (2019)

    Fulltext@MSK | Save
  • Transcriptional and post-transcriptional regulation of ribonucleotide reductase (RRM2) control its oncogenic role in prostate cancer progression
    Meeting Abstract

    Mazzu, Y. Z.; Armenia, J.; Chakraborty, G.; Yoshikawa, Y.; Gerke, T. A.; Atiq, M. O.; Stopsack, K. H.; Komura, K.; Lee, G. S. M.; Mucci, L. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • BRCA2-RB1 co-loss and ADT resistance in aggressive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Armenia, J.; Mazzu, Y. Z.; Stopsack, K. H.; Atiq, M. O.; Chadalavada, K.; Nanjangud, G.; Khan, N.; Komura, K.; Yoshikawa, Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in prostate cancer
    Meeting Abstract

    Mazzu, Y. Z.; Gerke, T. A.; Chakraborty, G.; Armenia, J.; Atiq, M. O.; Komura, K.; Yoshikawa, Y.; Lee, G. S. M.; Mucci, L. A.; Kantoff, P. W.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent deletion of BRCA2 and RB1 and aggressive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Armenia, J.; Mazzu, Y. Z.; Nanjangud, G.; Chadalavada, K.; Atiq, M. O.; Komura, K.; Yoshikawa, Y.; Khan, N.; Du, S. Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Targeting poor-prognosis subtypes of prostate cancer by inhibition of DNA repair gene ribonucleotide reductase small subunit M2
    Meeting Abstract

    Mazzu, Y. Z.; Armenia, J.; Chakraborty, G.; Yoshikawa, Y.; Gerke, T. A.; Coggins, S. A. A.; Qiu, X.; Atiq, M.; Stopsack, K. H.; Lee, G. S. M.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save